Ryme Medical Overview
- Year Founded
-
2021
- Status
-
Private
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$6.3M
- Investors
-
4
Ryme Medical General Information
Description
Developer of catheter-based therapies designed to treat patients with chronic bronchitis and emphysema. The company focuses on addressing chronic obstructive pulmonary disease by targeting the sympathetic nervous system, taking away its impact, and alleviating the suffering of those who struggle to breathe, enabling patients to have better treatment and breathe without much struggle.
Contact Information
Website
www.rymemedical.comCorporate Office
- 2495 Hospital Drive
- Suite 300
- Mountain View, CA 94040
- United States
Corporate Office
- 2495 Hospital Drive
- Suite 300
- Mountain View, CA 94040
- United States
Ryme Medical Timeline
Ryme Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A) | 19-Aug-2024 | $6.3M | Completed | Startup | ||
| 2. Early Stage VC (Series A) | 03-Feb-2023 | Completed | Startup | |||
| 1. Seed Round | $5.67M | $5.67M | Completed | Startup |
Ryme Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Ryme Medical Patents
Ryme Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260345218-A1 | Cryotherapeutic devices, systems, and methods for targeted lung neuromodulation | Pending | 04-Mar-2025 | ||
| WO-2026187949-A1 | Cryotherapeutic devices, systems, and methods for targeted lung neuromodulation | Pending | 04-Mar-2025 | ||
| AU-2023365504-A1 | Cryotherapeutic systems and methods for targeted lung neuromodulation therapies | Pending | 20-Oct-2022 | ||
| EP-4604861-A1 | Cryotherapeutic systems and methods for targeted lung neuromodulation therapies | Pending | 20-Oct-2022 | ||
| US-20240130775-A1 | Cryotherapeutic systems and methods for targeted lung neuromodulation therapies | Pending | 20-Oct-2022 | A61B18/02 |
Ryme Medical Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Epidarex Capital | Venture Capital | Minority | ||
| Seroba Life Sciences | Venture Capital | Minority | ||
| Fogarty Innovation | Accelerator/Incubator | Minority | ||
| Santé Ventures | Venture Capital | Minority |
Ryme Medical FAQs
-
When was Ryme Medical founded?
Ryme Medical was founded in 2021.
-
Where is Ryme Medical headquartered?
Ryme Medical is headquartered in Mountain View, CA.
-
What industry is Ryme Medical in?
Ryme Medical’s primary industry is Drug Discovery.
-
Is Ryme Medical a private or public company?
Ryme Medical is a Private company.
-
What is the current valuation of Ryme Medical?
The current valuation of Ryme Medical is .
-
What is Ryme Medical’s current revenue?
The current revenue for Ryme Medical is .
-
How much funding has Ryme Medical raised over time?
Ryme Medical has raised $22M.
-
Who are Ryme Medical’s investors?
Epidarex Capital, Seroba Life Sciences, Fogarty Innovation, and Santé Ventures have invested in Ryme Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process